Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Low-dose warfarin reported to prevent recurrent venous thromboembolism

March 4, 2003

CPMP recommends removal of contraindication for i.v. fibrinolytic use in diabetic patients

March 4, 2003

Broad-spectrum antithrombotic properties described for SSR-182289A

Feb. 28, 2003

Nuvelo reveals alfimeprase program progress in 2002

Feb. 27, 2003

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Feb. 27, 2003

Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation

Feb. 20, 2003

Merck designs new factor Xa and/or factor VIIa inhibitors

Feb. 20, 2003

Aventis claims novel factor VIIa inhibitors

Feb. 19, 2003

Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team

Feb. 17, 2003

Eptacog alfa in intracerebral hemorrhage

Feb. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...